@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:compare . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:52:16.134346"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "with standard care alone" . rdf:OBJECT-POSITION rdfs:label "150"^^xsd:integer . rdf:PREDICATE rdfs:label "compared" . rdf:PREDICATE-POSITION rdfs:label "[136]" . rdf:SUBJECT rdfs:label "use of intravenous dexamethasone plus standard care" . rdf:SUBJECT-POSITION rdfs:label "103"^^xsd:integer . rdfs:ABSTRACT-UID ns3:50 "kmvq6bit" . rdfs:SENTENCE rdfs:label "Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days." . rdfs:TRIPLE-UID ns2:kmvq6bit-TRIPLE-ABSTRACT-12 "kmvq6bit-TRIPLE-ABSTRACT-12" . rdfs:label "dexamethasone" . rdfs:label "standard" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "Ut7ytlydK9k0o7bbbM2Hz+koMqJ9GIAFXF4mGWYcXIGZsEvHDOsRhUh36C/jyK9ny3QReYs4/7CWLlgkU/0PsnllmmKT2ZPVHj/wqi3WfhBFD/oIHQdb7Noze2tnm/L2VLiIxwsPStR1ux+kd430EW/4VJJp8Uj9hOS2pzyU3X0="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:52:16.134346"^^xsd:dateTime; prov:wasAttributedTo . }